Healthcare | December 30, 2022
Eye-Q inaugurates its new facility in Yamunanagar
The new facility will be able to handle four times as many patients as the previous facility.
The new facility will be able to handle four times as many patients as the previous facility.
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
He has published more than 100 research papers in several prestigious national and international journals
More women centric initiatives being the need of the hour for holistic development
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
The girl child anthem will portray a celebration of a girl child.
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
